Lifecore Biomedical (LFCR)
NASDAQ:LFCR
LFCR Analyst Ratings
Strong Buy
3 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LFCR Stock 12 Month Forecast
Average Price Target
$6.50
▼(-15.69% Downside)
| Highest Price Target$9.00 | Average Price Target$6.50 | Lowest Price Target$5.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Barrington
$5.5
Buy
-28.66%
Downside
Reiterated
03/27/26
Stephens
$8.5→$5
Hold
-35.15%
Downside
Reiterated
03/17/26
William Blair
―
Buy
―
Reiterated
03/17/26
Craig-Hallum
$10→$9
Buy
16.73%
Upside
Assigned
03/17/26
KeyBanc
―
Hold
―
Reiterated
12/29/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barrington
$5.5
Buy
-28.66%
Downside
Reiterated
03/27/26
Stephens
$8.5→$5
Hold
-35.15%
Downside
Reiterated
03/17/26
William Blair
―
Buy
―
Reiterated
03/17/26
Craig-Hallum
$10→$9
Buy
16.73%
Upside
Assigned
03/17/26
KeyBanc
―
Hold
―
Reiterated
12/29/25
Best Analysts Covering Lifecore Biomedical
3 Months
xxx
Success Rate
10/17 ratings generated profit
Average Return
+5.57%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 58.82% of your transactions generating a profit, with an average return of +5.57% per trade.
1 Year
Success Rate
5/17 ratings generated profit
Average Return
+2.06%
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 29.41% of your transactions generating a profit, with an average return of +2.06% per trade.
2 Years
xxx
Success Rate
3/17 ratings generated profit
Average Return
-2.42%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 17.65% of your transactions generating a profit, with an average return of -2.42% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LFCR Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
1
0
0
2
2
Buy
6
6
3
6
4
Hold
3
3
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
9
4
9
7
Each month's total comprises the sum of three months' worth of ratings.
LFCR Financial Forecast
LFCR Stock Forecast FAQ
What is LFCR’s average 12-month price target, according to analysts?
Based on analyst ratings, Lifecore Biomedical’s 12-month average price target is 6.50.
What is LFCR’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for LFCR, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LFCR a Buy, Sell or Hold?
Lifecore Biomedical has a consensus rating of Strong Buy which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is Lifecore Biomedical’s price target?
The average price target for Lifecore Biomedical is 6.50. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $9.00 ,the lowest forecast is $5.00. The average price target represents -15.69% Decrease from the current price of $7.71.
The highest analyst price target is $9.00 ,the lowest forecast is $5.00. The average price target represents -15.69% Decrease from the current price of $7.71.
What do analysts say about Lifecore Biomedical?
Lifecore Biomedical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of LFCR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.